Drawing for TRIALSCOPE ENGAGE

USPTO serial 88519465

TRIALSCOPE ENGAGE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
NEW APPLICATION PROCESSING

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TRIALSCOPE ENGAGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kurt D. Olender

KURT D. OLENDER OLENDERFELDMAN LLP422 MORRIS AVESUMMIT, NJ 07901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Software-as-a-Service (SaaS) services, namely, hosting software for use by others in the pharmaceutical and life sciences industries for workflow and content management for clinical trial registration and clinical trial disclosure data; Software-as-a-Service (SaaS) services, namely, hosting software for use by others in the pharmaceutical and life sciences industries to facilitate regulatory and legal compliance for the clinical trial registration, disclosure and reporting processACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 25, 2019MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jul 25, 2019ABN1ABANDONMENT - EXPRESS MAILED—
Jul 25, 2019MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jul 20, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance